Evidence explainerVitamin C (ascorbic acid vs buffered vs liposomal)
Vitamin C and Colds: What 10,000 People in Trials Taught Us (It’s Not What the Label Implies)
Regular vitamin C did not lower the odds of catching a cold for most people. It did shorten colds a little, and it halved cold risk in one very specific group.
Key takeaways
- In general-population trials with 10,708 people, regular vitamin C did not meaningfully lower cold risk (RR 0.97) [1].
- Regular vitamin C shortened colds by 8% in adults and 14% in children [1].
- Starting vitamin C after a cold began showed no consistent benefit [1].
- In marathon runners, skiers and soldiers under extreme physical stress, cold risk was roughly halved (RR 0.48) [1].
- The adult upper limit is 2,000 mg/day; above it, diarrhea, nausea and cramps become more likely [2].
The evidence, graded
Pulled from our monograph evidence tables. Grades follow our evidence-grading policy.
- No effectNo effectChance of catching a cold, general populationNo meaningful reduction in cold risk (RR 0.97; 95% CI 0.94 to 1.00). Regular vitamin C shortened colds by 8% in adults and 14% in children; vitamin C started after symptoms began had no consistent effect.
- Grade BWorsenedChance of catching a cold under heavy physical stressCold risk was roughly halved (RR 0.48; 95% CI 0.35 to 0.64).
- Grade BWorsenedSystolic blood pressureSystolic blood pressure fell by 3.0 mmHg on average; larger drops were seen in people with hypertension (-3.2 mmHg) and diabetes (-4.6 mmHg).
For most people: no fewer colds
The Cochrane review pooled community trials in children and adults taking at least 0.2 g/day of vitamin C regularly [1]. Among 10,708 participants, cold risk barely moved (risk ratio 0.97) [1].
Colds were somewhat shorter with regular use: 8% in adults and 14% in children [1]. For a week-long cold, 8% is roughly half a day. Taking vitamin C only after symptoms started showed no consistent effect [1].
The exception: extreme physical stress
In 5 trials of 598 marathon runners, skiers and soldiers on subarctic exercises, regular vitamin C roughly halved cold risk (RR 0.48) [1]. That is a consistent result, but in a narrow group, which is why we grade it B and do not extend it to everyday life.
Other things vitamin C does in trials
A 2023 meta-analysis of 20 short trials found vitamin C lowered systolic blood pressure by 3.0 mmHg on average, with larger drops in people with hypertension or diabetes [3]. The trials ran a median 6 weeks and did not study long-term outcomes [3].
How much is too much
The adult RDA is 90 mg/day for men and 75 mg/day for women, and people who smoke need 35 mg/day more [2]. The upper limit is 2,000 mg/day, set to avoid diarrhea and other gut effects of unabsorbed vitamin C [2].
NIH flags people with hereditary hemochromatosis, because vitamin C raises iron absorption, and notes that high intakes raise urinary oxalate, with the clearest stone link in people with pre-existing kidney or oxalate problems [2]. Anyone in chemotherapy or radiation should tell their oncology team about vitamin C use [2].
For colds, zinc has a somewhat stronger treatment signal: see zinc for colds. For fancier forms, see is liposomal vitamin C worth it.
Keep reading
Full monographs
Related articles
- Liposomal, Buffered or Ester-C: Is Fancy Vitamin C Worth Paying More For?
- Zinc for Colds: About 2 Days Shorter, but Only If You Use It the Way the Trials Did
- 400 IU of Vitamin E Is Either 268 mg or 180 mg. The "d" or "dl" on the Label Decides
- Ashwagandha for Stress and Sleep: What the Trials Found, and Why the Results Vary So Much
Browse the full Supplement & Nutrient Encyclopedia or all supplement articles.
References
- [1]Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev, 2013.
- [2]Vitamin C: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements, 2025.
- [3]Vitamin C supplementation showed greater effects on systolic blood pressure in hypertensive and diabetic patients: an updated systematic review and meta-analysis of randomised clinical trials. Int J Food Sci Nutr, 2023.
